MAR 22, 2021 8:00 AM PDT

Impact of Global Surveillance on Diagnostic Tools

Speaker

Abstract

Date:  March 22, 2021

Time: 8:00am PDT,  11:00am EDT

 

Viral diversity presents an ongoing challenge for diagnostic tests, which must be designed to accurately detect all current and future circulating strains.  High level of viral genetic diversity has important implications for patient management as number of diagnostic tests from screening, diagnosis to monitoring are critical for the continuum of care.  Recognizing the importance of this issue, twenty eight years ago Abbott initiated a comprehensive program to monitor global diversification of certain pathogens and search for newly emerging variants, assemble large volume panels of genetically and geographically diverse strains, and develop strategies to determine the impact of viral diversity on assays used for detecting and monitoring infection. Over the course of the SARS-CoV-2 pandemic, the Abbott Global Surveillance program has been closely monitoring variants of concern and their impact on diagnostic assay performance.  In addition to viral pathogen monitoring, this team also identifies and develops emerging diagnostic disease markers such as HBV RNA.  Recently, the program expanded its expertise and formed a first-of-its-kind global scientific and public-health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.

 

Learning Objectives:

  • Discuss and better understand viral diversity and the impact it has on diagnostic tools

  • Explore SARS-CoV-2 surveillance: Where are we at today?

  • Discuss HBV DNA or RNA for patient management

  • Discuss how to stay ahead of the next pandemic with Abbott’s Pandemic Defense Coalition

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
Loading Comments...
Show Resources